Latest filing published 13 May 2021 for GlaxoSmithKline plc, €312.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
N Hirons: trading record in brief
N Hirons appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Over a trading history stretching from 11 July 2016 to 12 May 2021, the count stands at 173 filings.
On the open market, the record shows 10 purchases worth €2,874 and 5 sales worth €799k. Netting one side against the other leaves €796k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 156 share grants. In 2021 alone, the filings show no purchases and 1 sale.
Half of the purchases are above €286 and half below. Of 10 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 13 May 2021: a share grant of €312, in GlaxoSmithKline plc. The latest purchase dates back some time: it was published 3,467 days ago, on 11 May 2017. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to N Hirons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20 shares@ £13.407London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-4
- 1,586.857 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-4
- 18 shares@ £12.9061London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-4
- 292 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-6
- 16 shares@ £13.0875London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3939649-0
- 26 shares@ £13.1365London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-4
- 20 shares@ £12.671London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-4
- 7,630 sharesN/AISIN GB0009252882FCA-NSM:3897443-4
- 3,599 shares@ £12.1132N/AISIN GB0009252882FCA-NSM:3897443-5
- 23,551 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-4
- 50,108 sharesN/AISIN GB0009252882FCA-NSM:3879317-5
- 4,019 sharesN/AISIN GB0009252882FCA-NSM:3878373-6
- 68,441 sharesN/AISIN GB0009252882FCA-NSM:3878367-6
- 20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-4
- 275 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-6
- 837.932 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-4
- 13 shares@ £13.88London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847478-0
- 19 shares@ £13.8721London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-4
- 18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-4
- 18 shares@ £14.02722.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-4
- 870 shares@ £10.3497.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3803557-1
- 18 shares@ £14.6233London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-4
- 266 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-6
- 806.806 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-5
- 16 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-4
25 of 172 declarations